Sino-Argi Leading Biosciences (603970) — Cash Flow Reinvestment Rate
Sino-Argi Leading Biosciences (603970) has a Cash Flow Reinvestment Rate of 0.79x as of December 2024, reinvesting CN¥555.63 Million (capex CN¥139.59K plus investments CN¥-555.49 Million) from operating cash flow of CN¥702.54 Million. Check cash flow quality index of Sino-Argi Leading Biosciences to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sino-Argi Leading Biosciences Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Sino-Argi Leading Biosciences across 10 annual periods. Explore Sino-Argi Leading Biosciences debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sino-Argi Leading Biosciences (2012–2024)
Year-by-year capital reinvestment analysis for Sino-Argi Leading Biosciences. For live market cap and broader valuation context, see market value of Sino-Argi Leading Biosciences.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.66x | CN¥204.14 Million | CN¥307.40 Million | CN¥2.18 Million | ▲ +76.9% |
| 2022 | 0.38x | CN¥576.44 Million | CN¥1.54 Billion | CN¥3.44 Million | ▲ +190.9% |
| 2021 | 0.13x | CN¥42.00 Million | CN¥325.42 Million | CN¥3.99 Million | ▼ -85.6% |
| 2020 | 0.90x | CN¥315.99 Million | CN¥352.12 Million | CN¥14.99 Million | ▲ +2409.1% |
| 2019 | 0.04x | CN¥7.83 Million | CN¥218.90 Million | CN¥2.67 Million | ▼ -90.3% |
| 2018 | 0.37x | CN¥24.18 Million | CN¥65.69 Million | CN¥8.99 Million | ▼ -18.9% |
| 2017 | 0.45x | CN¥235.35 Million | CN¥518.83 Million | CN¥55.39 Million | ▲ +56.3% |
| 2016 | 0.29x | CN¥44.17 Million | CN¥152.22 Million | CN¥36.85 Million | ▲ +90.0% |
| 2014 | 0.15x | CN¥6.17 Million | CN¥40.41 Million | CN¥6.17 Million | ▲ +862.2% |
| 2012 | 0.02x | CN¥1.74 Million | CN¥109.43 Million | CN¥1.74 Million | — |